Castle Biosciences, Inc. - Common stock - fluxo de caixa trimestral (NASDAQ:CSTL) | MetaTrader

Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas

Total de ativos 531.24 M501.71 M544.73 M562.79 M578.56 M547.8 M Total de passivos 75.4 M61.41 M89.35 M95.74 M107.68 M86.39 M Capital total 455.83 M440.31 M455.38 M467.05 M470.87 M461.42 M Total de passivos e patrimônio líquido 531.24 M501.71 M544.73 M562.79 M578.56 M547.8 M Dívida total 9.74 M8.92 M10.04 M10.05 M10.16 M10.07 M Dívida líquida 9.74 M8.92 M-455.95 M-479.48 M-472.64 M-449.54 M

Notícias

BTIG reduz preço-alvo da Castle Biosciences devido ao aumento de custos

Castle Biosciences supera previsões no 1º tri e eleva guidance para 2026

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises

JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus

AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales

Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know